| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1606442A Treatments for restless legs syndrome |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1605362A Compound calcium phosphate/Chinese medicine bone alternate material and its preparing method |
| 04/13/2005 | CN1605350A Medicine for treating hyperosteogeny |
| 04/13/2005 | CN1605348A Medicinal for treating rheumatism and its preparation |
| 04/13/2005 | CN1196708C Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196685C Pyrimidine derivatives |
| 04/13/2005 | CN1196682C 4-pyridinyl-N-acyl-L-phenylalanines |
| 04/13/2005 | CN1196491C Ointment for healing trauumatic injury |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/13/2005 | CN1196480C Application of calcium L-threonate in preparting drug of curing or preventing fracture |
| 04/12/2005 | US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878723 Carbocyclic and/or heterocyclic amino carboxylic acids, e.g., 2-aminomethyl-6-(p-benzylphenoxy)hexanoic acid; leukotriene A4 hydrolase; treating arthritis and psoriasis; hematoprotective and antimitotic agents |
| 04/12/2005 | US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878702 Anti-inflammatory agents |
| 04/12/2005 | US6878690 Compounds and methods |
| 04/12/2005 | US6878522 Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2229316C Calcitriol derivatives and their uses |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005030803A1 Therapeutic molecules |
| 04/07/2005 | WO2005030773A1 Novel pyrazolopyrimidine derivatives |
| 04/07/2005 | WO2005030728A1 Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases |
| 04/07/2005 | WO2005030725A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 04/07/2005 | WO2005030244A1 Agent for promoting osteogenesis and/or inhibiting bone resorption |
| 04/07/2005 | WO2005030233A1 Active oxygen scavenging agent and process for producing the same |
| 04/07/2005 | WO2005030190A1 Natural menaquinone 7 compositions |
| 04/07/2005 | WO2005013947A3 Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer |
| 04/07/2005 | WO2004073741A8 Remedy for spinal injury containing interleukin-6 antagonist |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 04/07/2005 | US20050075488 Interleukin-1 beta antibodies |
| 04/07/2005 | US20050075396 Modulation of type 2 diabetes and drug delivery |
| 04/07/2005 | US20050075373 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/07/2005 | US20050075334 Novel compounds |
| 04/07/2005 | US20050075330 Dipeptidyl peptidase inhibitors |
| 04/07/2005 | US20050075319 Method of treatment using bisphosphonic acid |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074496 Utilizing such as fucoidan to treat surgical adhesions, arthritis, psoriasis; nontoxic, reduced side effects |
| 04/07/2005 | US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 04/07/2005 | US20050074441 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 04/07/2005 | US20050074436 Systems and methods for treating patients with processed lipoaspirate cells |
| 04/07/2005 | US20050074434 Remedies for metabolic bone diseases |
| 04/07/2005 | CA2540006A1 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 04/07/2005 | CA2539976A1 Therapeutic beta aminoacids |
| 04/07/2005 | CA2539731A1 Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases |
| 04/07/2005 | CA2539445A1 Agent for promoting osteogenesis and/or inhibiting bone resorption |
| 04/06/2005 | EP1520856A1 Androgen receptor agonist |
| 04/06/2005 | EP1520043A2 METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 04/06/2005 | EP1519961A1 Low molecular weight oversulfated polysaccharide |
| 04/06/2005 | EP1519960A2 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 04/06/2005 | EP1519939A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/06/2005 | EP1519922A1 Di-aryl-substituted ethane pyridone pde4 inhibitors |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519753A1 Pharmaceutical combination of a thromboxane a2 receptor antagonist and a cox-2 inhibitor |
| 04/06/2005 | EP1519749A1 Chemotactic factor inhibitor for modulating inflammatory reactions |
| 04/06/2005 | EP1519744A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1519733A1 Compositions for cancer therapy comprising saponins or sapogenins |
| 04/06/2005 | EP1519730A1 Novel use of imidazotriazinones |
| 04/06/2005 | EP1480627A4 Methods of reducing angiogenesis |
| 04/06/2005 | EP1414817B1 substituted isoindoles and the use thereof |
| 04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP1113809B1 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | CN1604968A Methods to treat diabetes and related conditions based on polymorphisms in the TCF-1 gene |
| 04/06/2005 | CN1604909A Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/06/2005 | CN1604904A Phosphonic acid compounds as inhibitors of serine proteases |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604900A 6-aminomorphinane derivatives, method for production and use thereof |
| 04/06/2005 | CN1604898A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-carboxamide derivatives, their preparation, their intermediates and pharmaceutical compositions containing the compounds |
| 04/06/2005 | CN1604788A High-concentration protein formulations and method of manufacture |
| 04/06/2005 | CN1603318A Genistein derivatives and their preparation process and use |
| 04/06/2005 | CN1602951A Nasally administered formulation of osteogenic growth peptide |
| 04/06/2005 | CN1602922A Externally applied Chinese traditional medicinal wine and its preparing method |
| 04/06/2005 | CN1602912A Ointment for treating closed fracture |
| 04/06/2005 | CN1602911A Externally applied medicine for treating arthralgia and its preparation |
| 04/06/2005 | CN1602909A Externally applied medicine for treating hyperosteogeny and preparation method thereof |
| 04/06/2005 | CN1602905A Externally applied medicine for treating hyperosteogeny and intervertebral disc protrusion and its preparation method |
| 04/06/2005 | CN1602885A Meridian dredging capsule containing panax pseudo-ginseng tri-alcohol saponin and its preparation process |
| 04/06/2005 | CN1602880A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602879A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602856A Calcium L-Threonate and soy bean isoflavone containing combination |
| 04/06/2005 | CN1195778C Cell adhension inhibitors |
| 04/06/2005 | CN1195745C Antiviral macrocyclic compounds |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/06/2005 | CN1195535C Chinese medicine for rheumatism |
| 04/06/2005 | CN1195513C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 04/05/2005 | US6875868 Pteridine compounds for the treatment of psoriasis |
| 04/05/2005 | US6875846 Heterologous polypeptide of the TNF family |